NLS Digital Health

Collaboration - May 11, 2022

Kaiku Health enters a strategic partnership

Kaiku Health and Roche are entering a strategic partnership in digital patient monitoring and management (DPMM). Kaiku Health and Roche aim to deploy digital tools to provide real-time symptom management by patients and Health Care Providers (HCPs), improve patient support, and provide personalized cancer care to cancer clinics and patients globally, they state. “Kaiku Health […]

Financing - May 7, 2022

Sidekick Health raises 55 million USD

Sidekick Health has raised 55 million USD in Series B funding. The round was led by London-based venture capital firm Novator Ventures, with additional participation from Wellington Partners, Asabys Partners, and Frumtak Ventures, as well as a US-based strategic investor that will be revealed at a later stage. Read more: Filling a void in chronic […]

Uncategorized - March 23, 2022

The right ingredients to spur growth

Swedish startup Acorai’s vision is to transform heart failure management, and during 2022 the company will have the opportunity to accelerate their solution on the French market. In July 2021 EIT Health launched a new joint accelerator program for Swedish start-ups in digital health and artificial intelligence (AI). At the inauguration of the accelerator program […]

Biotech Business - February 15, 2022

Capitainer and Attana sign collaboration agreement

The two companies have signed an agreement with the goal of offering broader and more patient-centric blood sampling solutions for the Attana AVATM system starting with COVID-19 immune profiling. Since November 2021, Attana has been performing comparative studies of finger stick capillary blood samples simultaneously collected by both test tubes and Capitainer qDBS cards (quantitative […]

Collaboration - November 26, 2021

Six Swedish start-ups selected to accelerate in the French market

In July EIT Health launched a new joint accelerator programme for Swedish start-ups in digital health and artificial intelligence (AI) with support from the Swedish Innovation Agency Vinnova within the framework of the strategic innovation partnership between Sweden and France. During 12 months six selected Swedish start-ups specialized in digital health and in artificial intelligence […]

Agreement - November 23, 2021

Boehringer Ingelheim signs license deal with Qlucore

Boehringer Ingelheim has ordered licenses from Qlucore at a value of approximately 142,000 EUR for the use of Qlucore Omics Explorer for two years. Boehringer Ingelheim is an existing Qlucore customer, and this license is for global use of Qlucore’s software. Qlucore Omics Explorer is software for research applications within the pharma, biotech and academic […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.